May 22, 2025:
In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights a wide range of updates from our member institutions. This issue covers the impact of budget cuts, celebrates distinguished faculty, honors Asian American Pacific Islander Desi Heritage Month, and announces key leadership additions. You’ll also find highlights of media coverage, participation in cancer conferences and forums, recent advances in cancer research and treatment, prevention and recurrence efforts, and the unveiling of new hospital facilities. Read More
In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights several investigators involved in detecting, decoding, and understanding genetic abnormalities as well as a potential drug target for treating aggressive pancreatic cancer and a tumor cell that may potentially stop tumor cell seeding and block cancer progression in breast cancer. We also feature a married couple at Penn State Cancer Institute that are building a research program using the MRIdian LINAC by Viewray, a Magnetic Res Magnetic Resonance Imaging (MRI)-guided linear accelerator, one of only 18 units currently open in the U.S. Learn about recent appointments, news grants, and more across our member institutions.
In this month’s Across the Consortium, we share exciting innovations developed by cancer researchers at our member institutions, including a wearable temperature sensor that can detect dangerous complications in hospitalized cancer patients and new dual-mechanism estrogen receptor inhibitors that could support the treatment of estrogen receptor-positive and metastatic breast cancers. We also share recent appointments and publications highlighting faculty at member institutions. See what’s new in this issue of Across the Consortium.
In this month’s Across the Consortium, cancer investigators, program managers, and administrators share their progress in oncology research and maintaining their excellent standing through NCI-designation and association accreditation. Learn about new tools that may help identify patients who are at high risk of cancer progression and relapse, as well as promising pre-clinical results to treat human estrogen-receptor positive breast cancer and their metastases in bone, brain, liver, and lungs. Also, find out which of our Big Ten Cancer Research Consortium members increased clinical trial enrollment by 167 percent, and minority participation in clinical trials to 56 percent of total enrollment. Read on to discover what’s new across the Big Ten Cancer Research Consortium.
In this month’s Across the Consortium, get to know some the cancer investigators in the Big Ten, what doctoral candidates and graduate students are researching, what publications and accolades have been shared with Big Ten researchers, and more.
In this edition of Across the Consortium, the Big Ten Cancer Research Consortium highlights cancer research ranging from scientists studying links between high cholesterol and breast cancer recurrence to “brain fog” and cognitive dysfunction after chemotherapy. We also share a study on the use of a robotic breast surgery option that may result in improved cosmetic outcomes without compromising cancer control, and how social media is influencing parents’ decisions about whether their children will or will not get the HPV Vaccine. Explore these studies, new appointments, publications, and other general news across the Big Ten CRC.
In this edition of Across the Consortium, we highlight researchers who are exploring cellular function as it relates to cancer, including drug molecules and genetic mutation, and those who are looking to the physical traits of the mantis shrimp to enhance removal of cancer cells during surgery. We also recognize investigators that are taking on new leadership roles and starting new programs to provide more comprehensive care at their cancer center, and highlight an oncology nurse as part of Nursing Oncology Month. Discover what is happening across the Big Ten CRC.
Researchers across the Big Ten Cancer Research Consortium are shedding light on new discoveries that could improve the health and lives of many in years to come through a host of precision medicine strategies. From boosting mitochondrial function in a subpopulation of T cells to analyzing vast amounts of data in populations, and synthesizing a rare compound found in a Native America shrub to combat a protein found in many cancers, these researchers are covering all the bases to make a difference. Learn about them and other investigators on the move in this issue of Across the Consortium.
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube